Circumsporozoite protein

The circumsporozoite protein (CSP) is a key protein found on the surface of the sporozoite stage of the Plasmodium parasite, which is responsible for causing malaria in humans. CSP plays a crucial role in the parasite's life cycle, particularly in the invasion of the host's liver cells.

Structure

CSP is characterized by its unique structure, which includes a central repeat region composed of multiple copies of a short amino acid sequence. This repeat region is flanked by an N-terminal domain and a C-terminal domain. The central repeat region is highly immunogenic and is the target of the host's immune response.

Function

The primary function of CSP is to facilitate the sporozoite's entry into the host's liver cells. It achieves this by interacting with hepatocytes and other host cell receptors. CSP is also involved in the motility of the sporozoite, enabling it to traverse the host's tissues and reach the liver.

Role in Malaria Vaccine Development

CSP is a major target for malaria vaccine development due to its critical role in the early stages of infection. The RTS,S/AS01 vaccine, also known as Mosquirix, is the most advanced malaria vaccine candidate and is based on the circumsporozoite protein. It includes a portion of the CSP fused with the hepatitis B surface antigen, aiming to elicit a strong immune response against the sporozoite stage of the parasite.

Immunological Aspects

The immune response to CSP is primarily mediated by antibodies that recognize the repeat region of the protein. These antibodies can neutralize the sporozoites and prevent them from invading liver cells. Additionally, T-cell responses to CSP can contribute to protective immunity by targeting infected liver cells.

Also see

• Plasmodium
• Malaria
• Sporozoite
• Hepatocyte
• RTS,S/AS01 vaccine

• File:Circumsporozoite protein CSP.svg